Keytruda and Pitavastatin calcium drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Keytruda (pembrolizumab) and Pitavastatin calcium (pitavastatin calcium). Common drug interactions include duodenitis among females and malignant neoplasm progression among males.

The phase IV clinical study analyzes what interactions people have when they take Keytruda and Pitavastatin calcium. It is created by eHealthMe based on reports of 72 people who take the same drugs from the FDA, and is updated regularly.

What is Keytruda?

Keytruda has active ingredients of pembrolizumab. It is often used in renal cell carcinoma. eHealthMe is studying from 57,404 Keytruda users. Check the latest studies of Keytruda.

What is Pitavastatin calcium?

Pitavastatin calcium has active ingredients of pitavastatin calcium. eHealthMe is studying from 1,710 Pitavastatin calcium users. Check the latest studies of Pitavastatin calcium.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

72 people who take Keytruda and Pitavastatin calcium together, and have interactions are studied.

Keytruda and Pitavastatin calcium drug interactions.

What are the common drug interactions of Keytruda and Pitavastatin Calcium, by gender? *:

female:

Duodenitis (inflammation of the duodenum)
Dysphonia (speech disorder attributable to a disorder of phonation)
Hypopituitarism (diminished hormone secretion by the pituitary gland, causing dwarfism in children and premature aging in adults)
Hypotension (abnormally low blood pressure)
Inflammation
Malnutrition (a condition that results from eating a diet in which certain nutrients are lacking)
Nausea (feeling of having an urge to vomit)
Non-small cell lung cancer (type of epithelial lung cancer)
Oral disorder (mouth disease)
Peritonitis (inflammation of the peritoneum, the thin tissue that lines the inner wall of the abdomen and covers most of the abdominal organs)

male:

Malignant neoplasm progression (cancer tumour came back)
Febrile neutropenia (fever with reduced white blood cells)
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)
Leukoderma (partial or total loss of skin pigmentation, often occurring in patches)
Pulmonary toxicity (side effects on the lungs)
Cholangitis (infection of the bile duct)
Constipation
Decreased appetite
Dehydration (dryness resulting from the removal of water)
Diarrhoea

What are the common drug interactions of Keytruda and Pitavastatin Calcium, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Dysphonia (speech disorder attributable to a disorder of phonation)
Oral disorder (mouth disease)
Rash macular (small, flat red spots)
Urogenital fistula

50-59:

Diarrhoea
Interstitial lung disease
Malnutrition (a condition that results from eating a diet in which certain nutrients are lacking)
Pyrexia (fever)

60+:

Malignant neoplasm progression (cancer tumour came back)
Febrile neutropenia (fever with reduced white blood cells)
Blood creatine phosphokinase increased
Cholangitis (infection of the bile duct)
Diarrhoea
Drug-induced liver injury (diseases of the liver that are caused by physician-prescribed medications)
Platelet count decreased
Pemphigoid (tense blisters on the skin)
Pyelonephritis (inflammation of kidney caused by bacteria)
Dehydration (dryness resulting from the removal of water)

What are the existing conditions these people have? *

Lung Cancer - Non-Small Cell (lung cancer): 21 people, 29.17%
High Blood Pressure: 17 people, 23.61%
Hyperlipidaemia (presence of excess lipids in the blood): 14 people, 19.44%
Constipation: 13 people, 18.06%
Dyslipidaemia (abnormal amount of lipids): 10 people, 13.89%
Type 2 Diabetes: 10 people, 13.89%
Lung Adenocarcinoma Stage Iv (the cancer has spread to other organs of the body, such as the other lung, brain, or liver): 10 people, 13.89%
Insomnia (sleeplessness): 7 people, 9.72%
Pain: 7 people, 9.72%
Endometrial Cancer: 7 people, 9.72%

* Approximation only. Some reports may have incomplete information.

Do you take Keytruda and Pitavastatin calcium?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously